Monoclonal Antibody Treatments Are The Fastest Growing Segment Fueling The Growth Of Allergy Treatment Market

https://www.coherentmarketinsights.com/market-insight/allergy-treatment-market-5143
Allergy Treatment Market



The global Allergy Treatment Market is estimated to be valued at US$ 20007.78 Million in 2023 and is expected to exhibit a CAGR of 6.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Allergy treatment products help in relieving allergic conditions caused by various environmental allergens like pollen, dust mites, animal dander, etc. These products provide effective relief from symptoms like sneezing, runny nose, watery eyes, etc. Allergy medications play a major role in managing allergies for millions of patients worldwide.

Market key trends:

One of the key trends in the allergy treatment market is the rising demand for monoclonal antibody therapies. Monoclonal antibodies target specific structures on the surface of cells or proteins involved in the inflammatory or allergic responses. These highly targeted therapies are replacing nonspecific antihistamines as first-line treatments for severe allergies and asthma. For example, Xolair (omalizumab), an antibody targeting immunoglobulin E (IgE), is one of the top-selling monoclonal antibody drugs. It has become a frontline therapy for treating allergic asthma and chronic idiopathic urticaria.

Segment Analysis

The global allergy treatment market is segmented by products into antihistamines, nasal spray, eye drops, and corticosteroids. The antihistamines segment currently dominates the market owing to its wide availability and low costs. Rising allergies and easy accessibility to over-the-counter antihistamines drive the growth of this segment.

Key Takeaways

The global Allergy Treatment Market Share is expected to witness high growth, exhibiting CAGR of 6.4% over the forecast period, due to increasing pollution and changing environmental conditions.

Regional analysis:
North America dominates the global allergy treatment market currently due to presence of major players and higher awareness levels regarding allergies.Asia Pacific is expected to be the fastest growing region in the allergy treatment market owing to rising pollution levels and growing cases of allergies in the region.

Key players:
Key players operating in the allergy treatment market are Stallergenes Greer PLC, Sanofi SA, Novartis International AG, Dermapharm Holding SE, Leti Pharma, Johnson & Johnson, GlaxoSmithKline PLC, Nicox SA, F. Hoffmann-La Roche Ltd., Allergy Therapeutics PLC, AbbVie Inc. (Allergan), Bausch Health Companies Inc., Teva Pharmaceutical Industries, ALK-Abello AS, and Alembic Pharmaceuticals Limited, among others.


Comments

Popular posts from this blog

Agricultural Micronutrients Market Growth Accelerated By Increasing Need For Improved Soil Fertility

Dairy Alternative Market Expected To Reach USD 26.01 Billion By 2023

Antimicrobial Additives Market Growth Accelerated By Rising Demand From End-Use Industries